Google+ Facebook Twitter Twitter

Histopathology scientist training

Jo Horne and Chris Fisher give a nuts-and-bolts guide to the new Histopathology Scientist Training Programme.

Traditional scientific training in histopathology leads to roles such as general management, quality management and training. Changes began in the early 21st century, with the formal development of simple and complex specimen dissection training roles, as well as the more recent introduction of national histopathology reporting programmes, leading to consultant roles for scientists in histopathology. As part of wider healthcare science training, the National School of Healthcare Science (NSHCS) oversees a variety of qualifications for healthcare scientists across 52 specialties, including the Scientist Training Programme (STP).

What is the histopathology STP?

The histopathology STP is a fully funded three-year programme of workplace and academic study, including a Masters degree in cellular science from Manchester Metropolitan University.

The STP histopathology curriculum has been updated for the next decade, to reflect the rapid changes in histopathology, including the expansion of molecular testing and digital innovations. The aim of the new curriculum is to develop healthcare scientists with knowledge and skills in a range of areas, to then act as a platform into more senior roles, dependent on professional interest and local service need.

Please click here to read the full article.

Image credit | iStock

Related Articles

A molecular biologist working with a microscope in a modern scientific Laboratory, we see a computer screen in the foreground- CREDIT - istock-1390303303

Precision pathology for cancer with new ai tool

A new AI tool interprets medical images with unprecedented clarity, according to the results of a new study.

Tech news: January 2024

This month's top tech news stories

My lab: digital pathology service

Rachael Nicholson gives a guided tour of the Medica MedPath Digital Pathology Hub in Runcorn.

AI grading the severity of a rare cancer

Professor Christina Messiou talks us through her study that shows AI is nearly twice as good at grading the aggressiveness of a rare form of cancer from scans as the current method.